Results for tag: "Pleural Effusion Drug"

The Pleural Effusion Drug market is a subset of the larger Respiratory Drugs market. It is composed of drugs used to treat pleural effusions, which are collections of fluid in the pleural cavity. These drugs are used to reduce the amount of fluid in the pleural cavity, reduce inflammation, and improve breathing. Commonly used drugs include diuretics, antibiotics, and corticosteroids. Other treatments, such as pleurodesis, may also be used. The Pleural Effusion Drug market is highly competitive, with many companies offering a variety of drugs. Some of the major players in the market include AstraZeneca, GlaxoSmithKline, Merck & Co., Pfizer, and Sanofi. Other companies, such as Novartis, Boehringer Ingelheim, and Daiichi Sankyo, also offer drugs for the treatment of pleural effusions. Show Less Read more